Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in psoriatic arthritis (ACCLAIM)
NCT00427362Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- May 2006
- Primary completion
- May 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in psoriatic arthritis (PsA), sponsored by Abbott Laboratories. Started May 2006; status: completed.
02
Drugs
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT00427362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427362.